Cardiol Therapeutics (CRDL) Interest & Investment Income: 2021-2022
Historic Interest & Investment Income for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $298,523.
- Cardiol Therapeutics' Interest & Investment Income rose 945.87% to $298,523 in Q3 2022 from the same period last year, while for Sep 2022 it was $527,712, marking a year-over-year change of. This contributed to the annual value of $84,584 for FY2021, which is 47.96% up from last year.
- As of Q3 2022, Cardiol Therapeutics' Interest & Investment Income stood at $298,523, which was up 98.92% from $150,073 recorded in Q2 2022.
- Over the past 5 years, Cardiol Therapeutics' Interest & Investment Income peaked at $298,523 during Q3 2022, and registered a low of $13,293 during Q1 2021.
- In the last 2 years, Cardiol Therapeutics' Interest & Investment Income had a median value of $28,543 in 2021 and averaged $84,325.
- Data for Cardiol Therapeutics' Interest & Investment Income shows a peak YoY soared of 945.87% (in 2022) over the last 5 years.
- Quarterly analysis of 2 years shows Cardiol Therapeutics' Interest & Investment Income stood at $22,029 in 2021, then spiked by 945.87% to $298,523 in 2022.
- Its Interest & Investment Income stands at $298,523 for Q3 2022, versus $150,073 for Q2 2022 and $57,088 for Q1 2022.